chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female registered nurse with reflex sympathetic dystrophy, cystitis interstitial, allergic reaction to cefaclor and sulfonamide allergy and a history of bronchiectasis who on unspecified dates was vaccinated with three doses of PNEUMOVAX 23 (lot# unknown). Concomitant therapy included amitriptyline hydrochloride (MSD), XANAX, RELAFEN, albuterol, NASACORT, cyclobenzaprine HCl (MSD) and ADVAIR. Subsequently the patient did not seroconvert to all 23 serotypes after three doses of vaccination. The titers were checked 4-6 weeks after administration. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. Not seroconverting to all 23 serotypes was considered to be disabling. Additional information has been requested.
Headache, metallic taste, tingling of tongue. BPs 148/88 (pulse 62), O2 sat 100%. BP 139/84 (pulse 64), O2 sat 100%. Benadryl 25 mg PO. Final BP 134/83 (pulse 55).
Information has been received from a 69 year old female consumer regarding herself. Medical history included thyroid disorder and hypertension. Concomitant medication included thyroid pill (not further specified), hypertension pill (not further specified) and low dose aspirin 81mg. On 14MAR2012 the consumer received ZOSTAVAX in the right arm subcutaneously, to prevent shingles. The consumer stated she had pain at the sight of insertion, which was in the arm muscle. She states her pharmacist advised her the vaccine should be in the fatty part of the arm, not where it was given. She stated her right arm, where she go the vaccine, is still sore, it has extended into her neck and she is now having headaches since 12SEP2012. She also stated that she can not extend her right arm completely. She will follow-up with her physician. Additional information has been requested.
Hepatitis B pediatric dose given instead of adult. It was caught and second pediatric dose was given to equal adult dose.
Shortness of breath, raise of blood pressure, profuse sweating, loss of taste and smell
Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Soreness). At the time of the report, MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Reporter did not allow further contact
Initial report received via search of the literature on 16 April 2013. This case contains information for 1 of 22 patients whose clinical data were provided. Information regarding the other 21 patients is captured in case numbers: 2013-05188, 2013-005251, 2013-005252, 2013-005253, 2013-005255 to 2013-005263, 2013-05268, 2013-05269, 2011-03827, 2006-03086, 1995-00668, 2006-03230, 1995-00224 and 2003-02926. From the published article, the authors reviewed charts of patients who had been hospitalized with Guillain-Barre Syndrome (GBS) from 1995 through 2006. Using a case-centered design, they compared the odds of vaccination in the 6 and 10 weeks prior to onset of GBS to the odds of vaccination during the same time intervals in all vaccinated individuals in the entire hospital population. While cases of GBS had been reported following a wide range of vaccines, a clear association had only been established with the 1976 H1N1 inactivated influenza vaccine. The authors confirmed 415 cases of which only 25 had received any vaccine in the six weeks prior to GBS onset. Vaccines received included TIV, 23-valent polysaccharide pneumococcal vaccine, tetanus-diphtheria combination vaccines, Hepatitis A and Hepatitis B. The large retrospective study did not find any association between influenza vaccine or any other vaccine and the development of GBS within 6 weeks following vaccination. According to the authors, the risk of GBS following any vaccine, including influenza vaccines, was extremely low. Regarding this case which involved a 62-year-old female patient who had received Combination tetanus and reduced diphtheria vaccine and Trivalent inactivated influenza vaccine, (manufacturers unknown; lot numbers, routes, sites and dates of administration not reported); and 12 days later reported the onset of GBS. No further information was provided. Outcomes were not reported. Documents held by sender: none.
patient fainted about 5 min after her shot. got pale and went limp. Mom caught her and we laid her on the ground. She came to almost right away.  We sat on the floor for about 15 minutes and then slowly worked her up to standing. She felt good enough to leave
No adverse effects; patient was administered VAQTA post expiration; This spontaneous report was received from a Nurse Practitioner refers to a patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 24-SEP-2019, the patient was vaccinated with 0.5 milliliter one dose of hepatitis a vaccine, inactivated(VAQTA) (lot # R027431, expiration date was reported as 09-SEP-2019, but upon internal validation established as 08-SEP-2019, 25/0.5 (units unspecified), anatomical location and route were not reported) post expiration for prophylaxis (expired product administered). No adverse effects reported. No product quality complaint involved. No additional information provided.
Heart palpitations; Tachycardia at rest; Edema to bilateral lower extremities excluding feet; This is a spontaneous report from a contactable nurse, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included diabetes insipidus, pituitary tumor and hypothyroidism. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient previously took influenza vaccine (MANUFACTURER UNKNOWN) and experienced allergy to the vaccine. The patient previously took hydromorphone hydrochloride (DILAUDID), sumatriptan (IMITREX), cefuroxime axetil (CEFTIN) and bupropion hydrochloride (WELLBUTRIN) and experienced drug allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021, the patient experienced heart palpitations, tachycardia at rest and edema to bilateral lower extremities excluding feet. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart palpitations, tachycardia at rest and edema to bilateral lower extremities excluding feet was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt experienced a large swelling and induration at site of vaccine. Hard lump formed over the next 2 days. No fever.
A few minutes after giving the hpv vaccine, the patient fainted, was unconscious for 40 seconds.
Stomach cramping from 4:35-5:45  Vomiting at 5:45
A non-serious report of administration of expired FLUMIST was received from an Air Force non-commissioned officer/health care professional concerning a 21-year-old male. The patient's medical history and concomitant medications were not reported. On 06-Oct-2008, FLUMIST was given via nasal administration by an immunization health technician. The vaccine was found to be expired when a nurse in the same clinic noted that the lot number of the administered FLUMIST (expiration date 24-Mar-2008) was different from the lot number of the other supply of FLUMIST with expiration date of 25-Dec-2008. The expired lot of FLUMIST was given to 17 adult individuals including this patient. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 09-Apr-2009: Product Complaint Investigation results.
Upper arm at the vaccinated site was swollen, tender to touch.  Pt has no fever. Suggested pt to take ibuprofen 600mg every 6 hours, and benadryl 25mg every 6 hours, also icing the site.
Received 1st dose 1 yr ago but no second dose; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 1 year ago from reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 26-MAY-2022 Reporter's Comments: The reporter was a healthcare professional from Doctor office. The reporter enquired if the patient received Shingrix 1st dose 1 year ago but never got 2nd dose, could patient still get the 2nd dose. The reporter stated that he/she was in the corrections system and hippa rules did not allow for this type (contact details) of information sharing. He/she just need a general information. Additional Supportive Information: The patient did not receive the 2nd dose of Shingrix till the time of reporting, which led to incomplete course of vaccination.
patient should have received the pediatric covid-19 vaccine, but the dose was administered incorrectly. The adult vial was used, but then mixed and administered with 1.3ml diluent and 0.2ml dose. mom reports no additional side-effects other than a sore arm at this time.
Information has been received from a pharmacist concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 07-DEC-2015, the patient was inadvertently vaccinated with ZOSTAVAX lot # K009198, an expiry date 27-SEP-2015 (dose, and route of administration and frequency were not reported). No adverse effects were reported. No further information was provided. Additional information has been requested.
After my first dose I started my period earlier than expected. After the second dose, I started my period earlier than expected again but this time I had huge blood clots that went on for over 24 hours every few minutes. I went to the emergency room and they could not pin point what caused it. I have a fibroid that has never caused issues and that?s the only thing they could think of. Since my second dose, my periods have been unbearable heavy and life altering. I just received my booster last week and was on my period. I finished my period on Sunday the 12th but then began to have big clots on the 13th. It stopped after a few hours and yesterday the 14th I had severe cramping. Today (the 15th) I am not clotting so far but am heavily bleeding again.
Redness, swelling at site. Chills, whole body soreness. Headache. Missed 1/2 day of work.
3 days after shot I began to experience pain in my elbow and wrist joint. I have also felt discomfort in other joints, but primarily in my left arm.
Woke up with extreme sore neck right side only. Over the next few days it moved to left side also.  Couldn't move neck without pain, used alternative methods to try and relieve it. Massage, Ice, Heat, and finally acupuncture. Tried Advil/ Aleve didn't relieve pain. After 3 acupuncture sessions 10/27, 10/31 & 11/3 and intermittent doses of Tylenol, I am able resume most activities. During the first 10 days, I was not able to do anything. I am an active healthy 68 year old that doesn't go to the Dr. very often, nor get sick or injured. I can't think of any other reason this happened other than the flu shot may be a possibility. It's interesting that I have heard of 3 other people with stiff and sore necks in the last month, 2 of which had flu shots. They only experienced minimal soreness.
patient received his first dose of the vaccine on 22Mar2021 and after that became infected, tested positive for Covid 19; patient received his first dose of the vaccine on 22Mar2021 and after that became infected, tested positive for Covid 19; This is a spontaneous report from a contactable pharmacist. A 46-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6204, expiry date Jun2021), via an unspecified route of administration on 22Mar2021 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The pharmacist stated that the patient received his first dose of the vaccine on 22Mar2021 and after that became infected, tested positive for Covid 19 on an unspecified date in 2021. The pharmacist reported that the patient has fully recovered from having Covid 19. The outcome of the events was recovered on an unspecified date in 2021. The patient asked the pharmacist for the soonest time that he can get his second dose if it was 10 days or longer.; Sender's Comments: As there is limited information in the case provided, the causal association between the event  COVID-19 and the suspect vaccine BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Pain in arm (upper) when arm is lifted above head, moved backward and then raised, sleeping since hours after administration and still the same a week later.
Shoulder pain,knee pain,ankle pain,knee locking Going for lab draw and X-ray on knee
W/in 2d of vaccine nausea/loose stool and fatigue. Resolved w/in 24h followed by an itchy, expanding erythema (R) deltoid.
Approximately 3 hours after injection, I experienced explosive diarrhea.  (That would be mid-afternoon).  That evening, I experienced ?brain fog? and lack of clarity. Have had headache every day since vaccination.
Tachycardia. Laying in bed watching TV, suddenly my heart was racing. I just stayed in bed and it went away after a few minutes.  Numbness in the arm: started that night and I would get numbness about every other day. Numbness lasts for about 10 hours and comes and goes throughout the day. About 6 weeks after the vaccine, i got numbness in the left leg. Now the numbness in the arm is pretty much gone but the leg numbness is there.
Fever, chills, muscle aches, rapid pulse, sinus blockage, right eye became dark red, headache, tiredness.
I got my first Shingles vaccine on 02-11-22.  Then on 02-21-22, I started having back and stomach pain. On 02-26-22, I broke out in shingles rash on the right side of my torso, front and back. This diagnosis was confirmed at Urgent Care and again by my doctor on 03-08-22.
Patient stated she was initially light headed, dizzy, and shaky.  After talking to her, she said has anxiety and did not have her medication with her.  When asked if she has had similar reaction to shots in the past she said she has had similar reaction.  She stated she was not having any trouble breathing but that her hand felt tingly.  (I did not observe any rash or hives on her.)  After 20 minutes, she said she felt is was her anxiety and was not getting better and requested we call an ambulance.  Store management called an ambulance and when they arrived, she stated she wanted to walk to the ambulance and the EMT's walked with her to the ambulance.
pt recv vax & temp went up to 102.4 2hr p/vax;child had rash on face & back;in evening rash spread all over body;16OCT98 child taken to MD & stated it was a rxn to MMR;19OCT98 child still has rash over entire body;temp down;
Intense soreness and aches, fever, tiredness, lack of appetite, chills, sensitivity to light
Reported substernal no shortness of breath b/p 130/84 @5:08 pm b/p 132/86 @5:22 5:26 has subsided, shakey
On February the 8th-I got shingles. It lasted for three weeks,  I had a telehealth  visit with Dr. and was given Gabapentin for pain and an antiviral Valtrex.
103 F temperature, shivering, head  & neck ache. Acetaminophen helped reduce intensity
Pt has flu-like symptoms for 2 days after receiving vaccine. Also, pt has nodule at injection site.
Have had muscle pain, weakness, cramping, twitching and fatigue since my shot.  Cramping became so severe as to limit range of motion in left leg.  Fatigue was substantial enough to stay home from work for two months.  I am slowly seeing a improvement in symptoms, but am still limited on activity and working part time.
Initial report was reported by healthcare professional on 11-Oct-2013: A 74 year old female, medical history included allergy (patient was not sure she had allergy or not) concomitant medication was unknown, received dose of FLUZONE HD lot# U4718AA at left deltoid on 09-Oct-2013. Patient was experiencing swelling, redness about 4 inches below injection site and a "mild fever, less than 100F on 10-Oct-2013). Event was not resolved on the day of reporting (11-Oct-2013). List of documents held by sender: none.
Symptoms right arm shoukder back and chest pain and numbness and neck stil numb no strength
A spontaneous report was received from a consumer concerning a 24-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events horrible migraine, out of work for 3 weeks, contracted covid the night after receiving the vaccination.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   horrible migraine, out of work for 3 weeks, contracted covid the night after receiving the vaccination.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), horrible migraine was unknown.The outcome of event(s), out of work for 3 weeks was unknown.The outcome of event(s), contracted covid the night after receiving the vaccination was unknown..
Left upper arm with redness, swelling, and hot to touch. Cellulitis and abscess of upper arm. Treated with CEFDINIR SUSPENSION  250 mg/5 mL Suspension for Reconstitution 6 mL PO twice daily; for 10 days Quantity: 120 Milliliter, 0 refills.
pt fainted about 45 min after the immunization, recovered and went home . She is reporting that she fainted again at home and felt very lethargic. She has been slowly getting better but reports extreme lethargia and being very tired, barely able to function. She had no previous reactions to vaccinations
Pale coloration to dusky coloration, irregular breathing, limp body. No fever prior to ER visit.
This spontaneous report was received from a pharmacist via a company representative and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 22-JUN-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route of administration, lot # and expiration date were not reported). On an unknown date in June 2017, the patient experienced an unspecified reaction for an unspecified reason. The outcome of the event was unknown. The relatedness between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
this is 1 of 3 pt from this facility to devel an inj site rxn characterized by redness, swelling, warmth & a knot 1 day p/vax;pt was seen by MD;
Pharmacist went over form with patient. She circled "heart" but said it was just hypertension. She thinks she may be prediabetic, but not confirmed with doctor yet.  Administered dose of Moderna Booster 0.25mL. Patient felt ok during administration and was advised to wait 15 minutes in the chairs next to the pharmacy per CDC guidline. Pharmacist went to check on patient at about 10 minutes, she was gone. Patient came back to pharmacy a few minutes later and said she'd almost fainted while trying to check out her purchases. Pharmacist had her sit down and got some water for her. Patient then went to Health machine and checked her BP with pharmacist -was 181/115. Advised pt to sit still for 5 minutes and try again - then was 153/??. Patient decided she wanted to go to urgent care, was advised by pharmacist to have someone else drive, grand daughter came and took patient to uc. Patient called later and said urgent care was not concerned by her reaction to the vaccine and advised her on some things to look for and sent her home.
Patient received Influenza vaccine 10/17/08. At 4:00 pm on 10/19/08 mother noticed patient's right arm was red, swollen and hot at 8:45 pm mother took patient to ER. Patient was seen by Dr. Mother was told patient had developed cellulitis and was started on Clindomicin-75 mg, 4x daily for 7 days. Patient followed up with MD on 10/20/08. Dr. diagnosed patient with an allergy to something in the vaccine. Lab work was drawn but results are not back as of yet.
she had a fever sore on the righthand corner of her lower lip; she had a little bit of a headache; This is a spontaneous report from a contactable consumer (patient). A 64 years old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 03Apr2021 10:45 (Lot Number: ER8729) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were none. The patient experienced she had a fever sore on the righthand corner of her lower lip, she had a little bit of a headache on 12Apr2021. Reported as: She said on 12Apr2021, she started having a lip reaction. She said she had a fever sore on the righthand corner of her lower lip. Reported her fever sore didn't come right after getting her first COVID 19 Vaccine. She said she took Tylenol right after she had the COVID 19 Vaccine because she had a little bit of a headache. Stated she was putting Vaseline on her fever sore. She said she was using the Vicks product to oil her lips. She said when her lips were dry, she used the Vicks product to moisten her lips.  The events did not lead to emergency room or physician office visit. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age. On 27-DEC-2013 the patient was vaccinated with ZOSTAVAX (lot number unknown, expiry date 10-DEC-2013) dose unknown. No concomitant medications were reported. The physician reported that the patient was vaccinated with expired ZOSTAVAX, expired on 10-DEC-2013 on 27-DEC-2013. No adverse effects were reported. Additional information has been requested.
Pt c/o tenderness at site after immunization, but there was nothing indicating pt had even rcvd vaccine. Pt went to school with no problems, ate dinner with no problems, but when mom went to bathe pt the area was bright red, hard and swollen as well as very warm at area of injection.
Received Pfizer vaccines on 11/9/21, 12/7/21. Tested positive for COVID by PCR on 5/15/22. Admitted to hospital on 5/19/22 d/t COVID pneumonia. History of mild persistent asthma.